POOR PROGNOSIS FOR CHEMOTHERAPY OF METASTATIC PROSTATE-CANCER

被引：0

|

作者：

GELDOF, AA

RAO, BR

DEVOOGT, HJ

机构：

[1] FREE UNIV AMSTERDAM,ACAD ZIEKENHUIS,DEPT ENDOCRINOL,1007 MC AMSTERDAM,NETHERLANDS

[2] FREE UNIV AMSTERDAM,ACAD ZIEKENHUIS,DEPT UROL,1007 MC AMSTERDAM,NETHERLANDS

来源：

ANTICANCER RESEARCH | 1985年 / 5卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：579 / 580

页数：2

相关论文

共 50 条

[21] METASTATIC PROSTATE-CANCER - HORMONAL TREATMENT
NABORS, W
CRAWFORD, ED
WORLD JOURNAL OF UROLOGY, 1990, 8 (01) : 34 - 39
[22] TREATMENT OF METASTATIC PROSTATE-CANCER OF THE SPINE
BRIDWELL, KH
UROLOGIC CLINICS OF NORTH AMERICA, 1991, 18 (01) : 153 - 159
[23] A DECADE OF EXPERIENCE WITH CHEMOTHERAPY FOR PROSTATE-CANCER
SLACK, NH
MURPHY, GP
UROLOGY, 1983, 22 (01) : 1 - 7
[24] MECHANISM BASED CHEMOTHERAPY FOR PROSTATE-CANCER
SHERIDAN, VR
TEW, KD
CANCER SURVEYS, 1991, 11 : 239 - 254
[25] PROSTATE-CANCER - PRESENT CONDITION OF CHEMOTHERAPY
BOLLAK, C
BERGERAT, JP
JACQUEMIN, D
BULLETIN DU CANCER, 1986, 73 (01) : 61 - 64
[26] A second chance for prostate-cancer chemotherapy?
不详
LANCET ONCOLOGY, 2003, 4 (03): : 131 - 131
[27] NEWER AGENTS FOR ANDROGEN DEPRIVATION IN PROSTATE-CANCER AND THE CURRENT STATUS OF CHEMOTHERAPY FOR PROSTATE-CANCER
SOLOWAY, MS
BRITISH JOURNAL OF UROLOGY, 1986, 58 (01): : 89 - 89
[28] LDH AS A PREDICTOR OF CHEMOTHERAPY RESPONSE AND SURVIVAL IN HORMONE REFRACTORY METASTATIC PROSTATE-CANCER (HRPC)
COX, EB
BERRY, WR
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 414 - 414
[29] MANIFESTATIONS OF ADVANCED PROSTATE-CANCER - PROGNOSIS AND TREATMENT
SURYA, BV
PROVET, JA
JOURNAL OF UROLOGY, 1989, 142 (04): : 921 - 928
[30] COMPLETE ANDROGEN BLOCKADE FOR METASTATIC PROSTATE-CANCER
PRESTI, JC
WESTERN JOURNAL OF MEDICINE, 1994, 160 (02): : 169 - 170

← 1 2 3 4 5 →